Suzuki, an automobile manufacturer, said that it will be difficult to procure parts in India, a main market where the medical system is in a critical situation due to the spread of the new coronavirus infection, from 1st to 9th next month. We have decided to stop all production at our factory in India.
Suzuki has three factories in its main market, India, but in India, the shortage of medical oxygen is becoming serious as the infection of the new corona spreads rapidly, and industrial oxygen is turned to medical use. Measures have been taken.
Suzuki's local business partners are short of industrial oxygen, making it impossible to weld parts, and Suzuki says that it is difficult to procure parts, three plants in India from 1st to 9th next month Decided to stop all production in.
According to Suzuki, this production suspension will not result in a reduction in production because it will respond ahead of schedule to the suspension of operations scheduled for June for maintenance of production equipment at the three plants.
Suzuki has continued to operate as usual, asking Japanese employees working locally to take measures against infections such as working from home, but it is a policy to make decisions while assessing the future infection situation, such as resuming production.